Page 129 - 《中国药房》2023年3期

视化分析[J]. 中国医院药学杂志，2020，40（16）：1714- study[J]. Eur J Health Econ，2019，20（2）：233-243.
1719. [25] HEIDER D，MATSCHINGER H，MEID A D，et al. The
[14] By The 2019 American Geriatrics Society Beers Criteria impact of potentially inappropriate medication on the de‐
®
Update Expert Panel. American Geriatrics Society 2019 velopment of health care costs and its moderation by the
updated AGS beers criteria® for potentially inappropriate number of prescribed substances. Results of a retrospec‐
medication use in older adults[J]. J Am Geriatr Soc，2019， tive matched cohort study[J]. PLoS One，2018，13（7）：
67（4）：674-694. e0198004.
[15] O'MAHONY D，O’SULLIVAN D，BYRNE S，et al. [26] OKPECHI I G，TINWALA M M，MUNEER S，et al.
STOPP/START criteria for potentially inappropriate pre‐ Prevalence of polypharmacy and associated adverse health
scribing in older people：version 2[J]. Age Ageing，2015， outcomes in adult patients with chronic kidney disease：
44（2）：213-218. protocol for a systematic review and meta-analysis[J].
[16] RENOM-GUITERAS A，MEYER G，THÜRMANN P A. Syst Rev，2021，10（1）：198.
The EU（7）-PIM list：a list of potentially inappropriate [27] OKTORA M P，ALFIAN S D，BOS H J，et al. Trends in
medications for older people consented by experts from polypharmacy and potentially inappropriate medication
seven European countries[J]. Eur J Clin Pharmacol，2015， （PIM） in older and middle-aged people treated for diabe‐
71（7）：861-875. tes[J]. Br J Clin Pharmacol，2021，87（7）：2807-2817.
[17] HOLT S，SCHMIEDL S，THÜRMANN P A. Potentially [28] ARNOLD I，STRAUBE K，HIMMEL W，et al. High
inappropriate medications in the elderly：the PRISCUS list prevalence of prescription of psychotropic drugs for older
[J]. Dtsch Arztebl Int，2010，107（31/32）：543-551. patients in a general hospital[J]. BMC Pharmacol Toxicol，
[18] KUHN-THIEL A M，WEIß C，WEHLING M，et al. Con‐ 2017，18（1）：76.
sensus validation of the FORTA （Fit fOR The Aged） List： [29] WOLFF J，HEFNER G，NORMANN C，et al. Polyphar‐
a clinical tool for increasing the appropriateness of phar‐ macy and the risk of drug-drug interactions and poten‐
macotherapy in the elderly[J]. Drugs Aging，2014，31（2）： tially inappropriate medications in hospital psychiatry[J].
131-140. Pharmacoepidemiol Drug Saf，2021，30（9）：1258-1268.
[19] KIM S O，JANG S，KIM C M，et al. Consensus validated [30] CHAO C T，TSAI H B，CHIANG C K，et al. Association
list of potentially inappropriate medication for the elderly between education level and potentially inappropriate
and their prevalence in south Korea[J]. Int J Gerontol， medication among older patients[J]. Aging Clin Exp Res，
2015，9（3）：136-141. 2018，30（1）：101-103.
[20] ROGNSTAD S，BREKKE M，FETVEIT A，et al. The [31] SUN W，TAHSIN F，ABBASS DICK J，et al. Educating
Norwegian General Practice （NORGEP） criteria for homecare nurses about deprescribing of medications to
assessing potentially inappropriate prescriptions to elderly manage polypharmacy for older adults[J]. West J Nurs
patients[J]. Scand J Prim Health Care，2009，27（3）： Res，2021：193945920982599.
153-159. [32] KRAUSE O，WIESE B，DOYLE I M，et al. Multidisci‐
[21] HANLON J T，SCHMADER K E. The medication appro‐ plinary intervention to improve medication safety in nur-
priateness index at 20：where it started，where it has been， sing home residents：protocol of a cluster randomised
and where it may be going[J]. Drugs Aging，2013，30 controlled trial （HIOPP-3-iTBX study）[J]. BMC Geriatr，
（11）：893-900. 2019，19（1）：24.
[22] HEIDER D，MATSCHINGER H，MEID A D，et al. Health [33] BITTER K，PEHE C，KRÜGER M，et al. Pharmacist-led
service use，costs，and adverse events associated with po‐ medication reviews for geriatric residents in German long-
tentially inappropriate medication in old age in Germany： term care facilities[J]. BMC Geriatr，2019，19（1）：39.
retrospective matched cohort study[J]. Drugs Aging， [34] CHOUKROUN C，LEGUELINEL-BLACHE G，ROUX-
2017，34（4）：289-301. MARSON C，et al. Impact of a pharmacist and geriatri‐
[23] SHEIKH REZAEI S，ŠINKOVEC H，SCHÖBERL A， cian medication review on drug-related problems in older
et al. Utilization of potentially inappropriate medication outpatients with cancer[J]. J Geriatr Oncol，2021，12（1）：
and risk of adverse drug events among older adults with 57-63.
chronic renal insufficiency：a population-wide cohort study [35] VAN MERENDONK L N，CRUL M. Deprescribing in
[J]. BMC Geriatr，2021，21（1）：117. palliative patients with cancer：a concise review of tools
[24] HYTTINEN V，JYRKKÄ J，SAASTAMOINEN L K， and guidelines[J]. Support Care Cancer，2022，30（4）：
et al. The association of potentially inappropriate medica‐ 2933-2943.
tion use on health outcomes and hospital costs in （收稿日期：2022-07-27 修回日期：2022-12-27）
community-dwelling older persons：a longitudinal 12-year （编辑：舒安琴）

中国药房 2023年第34卷第3期 China Pharmacy 2023 Vol. 34 No. 3 · 375 ·